Drugs / budesonide/formoterol
last change Mar 2016 re-read 2 minutes ago

budesonide/formoterol

Developed for
asthma
Investigated by
AstraZeneca

Trials 1 · a red edge is where a trial was stopped

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00652002 Jul 2002 → Jan 2004 asthma AstraZeneca Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as budesonide/formoterol ClinicalTrials.gov intervention name — accepted as the source's own label NCT00652002
Route Inhaled “budesonide/formoterol (BUD/FM) via pressurized metered-dose inhaler (pMDI)” PMID 27039236 Mar 2016